Shuairu Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shuairu Zhu has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Mei Yang
Department of Laboratory Medicine/Clinical Laboratory Medicine Research Center, West China Hospital
7 shared publicationsHongwei Xu
Department of Laboratory Medicine/Clinical Laboratory Medicine Research Center, West China Hospital
5 shared publications- Binwu Ying
Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, West China Hospital Sichuan University, Sichuan Clinical Research Center for Laboratory Medicine Sichuan P. R. China
4 shared publications Binwu Ying
Department of Laboratory Medicine/Clinical Laboratory Medicine Research Center West China Hospital Sichuan University Chengdu Sichuan 610041 China
3 shared publicationsWanding Cui
Department of Laboratory Medicine/Clinical Laboratory Medicine Research Center, West China Hospital
2 shared publicationsXiaohua Yuan
Department of Laboratory Medicine/Clinical Laboratory Medicine Research Center, West China Hospital
2 shared publications
Latest Publications
- 25 September 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (40) , 55909-55922
Dual-Single-Atom Ruthenium–Copper Anchored on Magnesium–Aluminum Layered Double Hydroxide Enhancing Dual-Enzymatic Activities for Synergistic Anti-Liver Cancer Therapy
Single-atom nanozymes (SANs), with their tunable metal active centers, enable the modulation of various enzyme activities for antitumor therapy. However, these materials encounter substantial challenges in cancer therapy owing to their limited biocompatibility and biodegradability. Additionally, the high-temperature pyrolysis process involved in their synthesis significantly restricts their practical, large-scale application. To address these challenges, we propose the construction of an LDH-based SAN exhibiting peroxidase-like (POD-like) activity and glutathione depletion capability. We successfully developed a SAN containing ruthenium (Ru) and copper (Cu) bimetallic atoms (MgAl-LDH/Ru/Cu), where Ru and Cu are distributed in single-atom dispersed states, forming nanodomains. The synergistic effects of the Ru/Cu bimetallic system enable MgAl-LDH/Ru/Cu to demonstrate superior POD-like and glutathione peroxidase-like (GPx-like) catalytic activities compared to those of MgAl-LDH/Ru or MgAl-LDH/Cu alone. Density functional theory calculations indicate that both Ru and Cu sites in MgAl-LDH/Ru/Cu exhibit lower energy barriers for POD-like and GPx-like reactions, likely due to enhanced electron loss states at the Ru/Cu bimetallic single-atom sites compared to those at Ru or Cu sites individually. Both in vitro and in vivo experiments demonstrate that the Ru/Cu bimetallic loading significantly outperforms the individual metal loadings of Ru or Cu in terms of anti-liver cancer efficacy. Importantly, by leveraging the precise correlation between the catalytic structural unit of MgAl-LDH-based SANs and enzyme activity, we further elucidated the potential contributions of POD-like and GPx-like activities to cancer therapy. MgAl-LDH-based multimetal SAN represents a synergistic multienzyme nanoplatform with a tunable elemental composition, paving the way for further investigations into the interplay between multienzyme activity and antitumor effects.
- 25 September 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (40) , 55909-55922
Dual-Single-Atom Ruthenium–Copper Anchored on Magnesium–Aluminum Layered Double Hydroxide Enhancing Dual-Enzymatic Activities for Synergistic Anti-Liver Cancer Therapy
Single-atom nanozymes (SANs), with their tunable metal active centers, enable the modulation of various enzyme activities for antitumor therapy. However, these materials encounter substantial challenges in cancer therapy owing to their limited biocompatibility and biodegradability. Additionally, the high-temperature pyrolysis process involved in their synthesis significantly restricts their practical, large-scale application. To address these challenges, we propose the construction of an LDH-based SAN exhibiting peroxidase-like (POD-like) activity and glutathione depletion capability. We successfully developed a SAN containing ruthenium (Ru) and copper (Cu) bimetallic atoms (MgAl-LDH/Ru/Cu), where Ru and Cu are distributed in single-atom dispersed states, forming nanodomains. The synergistic effects of the Ru/Cu bimetallic system enable MgAl-LDH/Ru/Cu to demonstrate superior POD-like and glutathione peroxidase-like (GPx-like) catalytic activities compared to those of MgAl-LDH/Ru or MgAl-LDH/Cu alone. Density functional theory calculations indicate that both Ru and Cu sites in MgAl-LDH/Ru/Cu exhibit lower energy barriers for POD-like and GPx-like reactions, likely due to enhanced electron loss states at the Ru/Cu bimetallic single-atom sites compared to those at Ru or Cu sites individually. Both in vitro and in vivo experiments demonstrate that the Ru/Cu bimetallic loading significantly outperforms the individual metal loadings of Ru or Cu in terms of anti-liver cancer efficacy. Importantly, by leveraging the precise correlation between the catalytic structural unit of MgAl-LDH-based SANs and enzyme activity, we further elucidated the potential contributions of POD-like and GPx-like activities to cancer therapy. MgAl-LDH-based multimetal SAN represents a synergistic multienzyme nanoplatform with a tunable elemental composition, paving the way for further investigations into the interplay between multienzyme activity and antitumor effects.
- 1 September 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (37) , 21582-21593
Manganese-doped nickel–iron layered double hydroxides for enhanced peroxidase, oxidase, and catalase activities
NiFeMn-20%-C demonstrated superior enzymatic activities compared to NiFeMn-20%, primarily due to differences in the doping sites of Mn. In NiFeMn-20%-C, Mn replaces both Ni and Fe sites, whereas in NiFeMn-20%, it substitutes only the Fe sites.
- 1 September 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (37) , 21582-21593
Manganese-doped nickel–iron layered double hydroxides for enhanced peroxidase, oxidase, and catalase activities
NiFeMn-20%-C demonstrated superior enzymatic activities compared to NiFeMn-20%, primarily due to differences in the doping sites of Mn. In NiFeMn-20%-C, Mn replaces both Ni and Fe sites, whereas in NiFeMn-20%, it substitutes only the Fe sites.
- 31 July 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (31) , e03072
Manganese‐Copper Co‐Doped NiFe‐LDH Nanosheets toward Multi‐Enzymatic Activities and Cascaded Synergistic Anti‐Liver Tumor Therapy
Primary liver cancer remains a significant global health challenge, with the majority of patients diagnosed at an unresectable stage, further complicated by liver dysfunction due to cirrhosis. To address these clinical hurdles, nanozyme‐based catalytic therapy has emerged as a promising strategy. However, its therapeutic efficacy is often limited by self‐protective mechanisms associated with the tumor microenvironment (TME), particularly the overexpression of glutathione (GSH) and hypoxia‐induced metabolic adaptation. In this study, a quaternary medium‐entropy layered double hydroxide (LDH) nanozyme, denoted as NiFeMnCu‐LDH is developed. This nanozyme exhibits peroxidase‐like, catalase (CAT)‐like, and oxidase‐like activities, facilitating the cascade generation of reactive oxygen species (ROS). Simultaneously, the oxygen produced by CAT mitigates hypoxia, while the glutathione peroxidase‐like activity drives the depletion of tumor antioxidants, effectively reprogramming the TME. Further in vitro experiments demonstrated that efficient production of ROS and scavenging of GSH induced substantial apoptosis in liver cancer cells. Additionally, mouse liver tumor models showed robust inhibition of tumor growth without systemic toxicity. This findings provide a framework for the precise engineering of nanozymes in advanced liver cancer treatment, addressing critical barriers within the TME and offering valuable insights into a mimetic multi‐enzyme synergy for translational applications.
- 31 July 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (31) , e03072
Manganese‐Copper Co‐Doped NiFe‐LDH Nanosheets toward Multi‐Enzymatic Activities and Cascaded Synergistic Anti‐Liver Tumor Therapy
Primary liver cancer remains a significant global health challenge, with the majority of patients diagnosed at an unresectable stage, further complicated by liver dysfunction due to cirrhosis. To address these clinical hurdles, nanozyme‐based catalytic therapy has emerged as a promising strategy. However, its therapeutic efficacy is often limited by self‐protective mechanisms associated with the tumor microenvironment (TME), particularly the overexpression of glutathione (GSH) and hypoxia‐induced metabolic adaptation. In this study, a quaternary medium‐entropy layered double hydroxide (LDH) nanozyme, denoted as NiFeMnCu‐LDH is developed. This nanozyme exhibits peroxidase‐like, catalase (CAT)‐like, and oxidase‐like activities, facilitating the cascade generation of reactive oxygen species (ROS). Simultaneously, the oxygen produced by CAT mitigates hypoxia, while the glutathione peroxidase‐like activity drives the depletion of tumor antioxidants, effectively reprogramming the TME. Further in vitro experiments demonstrated that efficient production of ROS and scavenging of GSH induced substantial apoptosis in liver cancer cells. Additionally, mouse liver tumor models showed robust inhibition of tumor growth without systemic toxicity. This findings provide a framework for the precise engineering of nanozymes in advanced liver cancer treatment, addressing critical barriers within the TME and offering valuable insights into a mimetic multi‐enzyme synergy for translational applications.
- 18 October 2024
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (43) , 29522-29534
Enhanced Peroxidase-like Activity of Ruthenium-Modified Single-Atom-Thick A Layers in MAX Phases for Biomedical Applications
Nanozymes have demonstrated significant potential as promising alternatives to natural enzymes in biomedical applications. However, their lower catalytic activity compared to that of natural enzymes has limited their practical utility. Addressing this challenge necessitates the development of innovative enzymatic systems capable of achieving specific activity levels of natural enzymes. In this study, we focus on enhancing the catalytic performance of nanozymes by introducing Ru atoms into the single-atom-thick A layer of the V2SnC MAX phase, resulting in the formation of V2(Sn0.8Ru0.2)C with Ru single-atom sites. The V2(Sn0.8Ru0.2)C MAX phase demonstrated an exceptional peroxidase-like specific activity of up to 1792.6 U mg-1, surpassing the specific activity of a previously reported horseradish peroxidase (HRP). Through X-ray photoelectron spectroscopy (XPS) and density functional theory (DFT) investigations, it has been revealed that both the V2C atom layers and single-atom-thick Sn readily accept a negative charge from Ru, leading to a reduction of the energy barrier for H2O2 adsorption. This discovery has enabled the successful application of V2(Sn0.8Ru0.2)C in the development of a lateral flow immunoassay for heart failure biomarkers, achieving a detection sensitivity of 4 pg mL-1. Additionally, V2(Sn0.8Ru0.2)C demonstrated exceptional broad-spectrum antibacterial efficacy. This study lays the groundwork for the precise design of MAX phase-based nanozymes with high specific activity, offering a viable alternative to natural enzymes for various applications.
- 18 October 2024
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (43) , 29522-29534
Enhanced Peroxidase-like Activity of Ruthenium-Modified Single-Atom-Thick A Layers in MAX Phases for Biomedical Applications
Nanozymes have demonstrated significant potential as promising alternatives to natural enzymes in biomedical applications. However, their lower catalytic activity compared to that of natural enzymes has limited their practical utility. Addressing this challenge necessitates the development of innovative enzymatic systems capable of achieving specific activity levels of natural enzymes. In this study, we focus on enhancing the catalytic performance of nanozymes by introducing Ru atoms into the single-atom-thick A layer of the V2SnC MAX phase, resulting in the formation of V2(Sn0.8Ru0.2)C with Ru single-atom sites. The V2(Sn0.8Ru0.2)C MAX phase demonstrated an exceptional peroxidase-like specific activity of up to 1792.6 U mg-1, surpassing the specific activity of a previously reported horseradish peroxidase (HRP). Through X-ray photoelectron spectroscopy (XPS) and density functional theory (DFT) investigations, it has been revealed that both the V2C atom layers and single-atom-thick Sn readily accept a negative charge from Ru, leading to a reduction of the energy barrier for H2O2 adsorption. This discovery has enabled the successful application of V2(Sn0.8Ru0.2)C in the development of a lateral flow immunoassay for heart failure biomarkers, achieving a detection sensitivity of 4 pg mL-1. Additionally, V2(Sn0.8Ru0.2)C demonstrated exceptional broad-spectrum antibacterial efficacy. This study lays the groundwork for the precise design of MAX phase-based nanozymes with high specific activity, offering a viable alternative to natural enzymes for various applications.
- 20 August 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (34) , 44361-44375
Smart Nanozymes for Diagnosis of Bacterial Infection: The Next Frontier from Laboratory to Bedside Testing
The global spread of infectious diseases caused by pathogenic bacteria significantly poses public health concerns, and methods for sensitive, selective, and facile diagnosis of bacteria can efficiently prevent deterioration and further spreading of the infections. The advent of nanozymes has broadened the spectrum of alternatives for diagnosing bacterial infections. Compared to natural enzymes, nanozymes exhibit the same enzymatic characteristics but offer greater economic efficiency, enhanced durability, and adjustable dimensions. The importance of early diagnosis of bacterial infection and conventional diagnostic approaches is introduced. Subsequently, the review elucidates the definition, properties, and catalytic mechanism of nanozymes. Eventually, the detailed application of nanozymes in detecting bacteria is explored, highlighting their utilization as biosensors that allow for accelerated and highly sensitive identification of bacterial infections and reflecting on the potential of nanozyme-based bacterial detection as a point-of-care testing (POCT) tool. A brief summary of obstacles and future perspectives in this field is presented at the conclusion of this review.
- 20 August 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (34) , 44361-44375
Smart Nanozymes for Diagnosis of Bacterial Infection: The Next Frontier from Laboratory to Bedside Testing
The global spread of infectious diseases caused by pathogenic bacteria significantly poses public health concerns, and methods for sensitive, selective, and facile diagnosis of bacteria can efficiently prevent deterioration and further spreading of the infections. The advent of nanozymes has broadened the spectrum of alternatives for diagnosing bacterial infections. Compared to natural enzymes, nanozymes exhibit the same enzymatic characteristics but offer greater economic efficiency, enhanced durability, and adjustable dimensions. The importance of early diagnosis of bacterial infection and conventional diagnostic approaches is introduced. Subsequently, the review elucidates the definition, properties, and catalytic mechanism of nanozymes. Eventually, the detailed application of nanozymes in detecting bacteria is explored, highlighting their utilization as biosensors that allow for accelerated and highly sensitive identification of bacterial infections and reflecting on the potential of nanozyme-based bacterial detection as a point-of-care testing (POCT) tool. A brief summary of obstacles and future perspectives in this field is presented at the conclusion of this review.
Extraordinary Structural Reconstruction of Nanolaminated Ta2FeC MAX Phase for Enhanced Oxygen Evolution Performance
Renewable energy technologies, such as water splitting, heavily depend on the oxygen evolution reaction (OER). Nanolaminated ternary compounds, referred to as MAX phases, show great promise for creating efficient electrocatalysts for OER. However, their limited intrinsic oxidative resistance hinders the utilization of conductivity in Mn+1Xn layers, leading to reduced activity. In this study, a method is proposed to improve the poor inoxidizability of MAX phases by carefully adjusting the elemental composition between Mn+1Xn layers and single‐atom‐thick A layers. The resulting Ta2FeC catalyst demonstrates superior performance compared to conventional Fe/C‐based catalysts with a remarkable record‐low overpotential of 247 mV (@10 mA cm−2) and sustained activity for over 240 h. Notably, during OER processing, the single‐atom‐thick Fe layer undergoes self‐reconstruction and enrichment from the interior of the Ta2FeC MAX phase toward its surface, forming a Ta2FeC@Ta2C@FeOOH heterostructure. Through density functional theory (DFT) calculations, this study has found that the incorporation of Ta2FeC@Ta2C not only enhances the conductivity of FeOOH but also reduces the covalency of Fe─O bonds, thus alleviating the oxidation of Fe3+ and O2−. This implies that the Ta2FeC@Ta2C@FeOOH heterostructure experiences less lattice oxygen loss during the OER process compared to pure FeOOH, leading to significantly improved stability. These results highlight promising avenues for further exploration of MAX phases by strategically engineering M‐ and A‐site engineering through multi‐metal substitution, to develop M2AX@M2X@AOOH‐based catalysts for oxygen evolution.
Extraordinary Structural Reconstruction of Nanolaminated Ta2FeC MAX Phase for Enhanced Oxygen Evolution Performance
Renewable energy technologies, such as water splitting, heavily depend on the oxygen evolution reaction (OER). Nanolaminated ternary compounds, referred to as MAX phases, show great promise for creating efficient electrocatalysts for OER. However, their limited intrinsic oxidative resistance hinders the utilization of conductivity in Mn+1Xn layers, leading to reduced activity. In this study, a method is proposed to improve the poor inoxidizability of MAX phases by carefully adjusting the elemental composition between Mn+1Xn layers and single‐atom‐thick A layers. The resulting Ta2FeC catalyst demonstrates superior performance compared to conventional Fe/C‐based catalysts with a remarkable record‐low overpotential of 247 mV (@10 mA cm−2) and sustained activity for over 240 h. Notably, during OER processing, the single‐atom‐thick Fe layer undergoes self‐reconstruction and enrichment from the interior of the Ta2FeC MAX phase toward its surface, forming a Ta2FeC@Ta2C@FeOOH heterostructure. Through density functional theory (DFT) calculations, this study has found that the incorporation of Ta2FeC@Ta2C not only enhances the conductivity of FeOOH but also reduces the covalency of Fe─O bonds, thus alleviating the oxidation of Fe3+ and O2−. This implies that the Ta2FeC@Ta2C@FeOOH heterostructure experiences less lattice oxygen loss during the OER process compared to pure FeOOH, leading to significantly improved stability. These results highlight promising avenues for further exploration of MAX phases by strategically engineering M‐ and A‐site engineering through multi‐metal substitution, to develop M2AX@M2X@AOOH‐based catalysts for oxygen evolution.